Inhibition of the catabolic enzyme UGCG inhibited proliferation and induced apoptosis of breast cancer cells and enhanced the inhibitory effects of chemotherapeutic drugs in vivo and in vitro [40]. Here, UGCG is linked to breast carcinoma.